Results 261 to 270 of about 149,153 (360)
Low body mass index (aOR 0.87 per unit) and high uterine weight (aOR 1.30 per 100 g) were associated with increased risk of vaginal cuff dehiscence following robot‐assisted total laparoscopic hysterectomy. Vaginal intercourse was the most common trigger (82%).
Silje Eilertsen Denstad +4 more
wiley +1 more source
Retrospective analysis of treatment and prognosis for clear cell carcinoma of the uterine cervix: 15-year experience at a single institution. [PDF]
Inomata Y +9 more
europepmc +1 more source
This illustration summarises our primary findings highlighting the rising incidence of certain extra‐digestive cancers among persons with IBD over the 25‐year study duration (left), and the relative rates of extra‐digestive cancer incidence and mortality among persons with IBD in recent years (2010–2019) compared to their age‐ and sex‐matched controls (
Sanjay K. Murthy +13 more
wiley +1 more source
Infectious diseases significantly impact equine health and welfare, causing illness and death, and loss of productivity globally. One such disease is ‘strangles’, a highly contagious upper respiratory condition in horses caused by Streptococcus equi subspecies equi (SEE).
M Jelocnik +11 more
wiley +1 more source
A Trichoadenoma/Trichoepithelioma/Trichoblastoma-like Lesion in the Uterine Cervix Focally Mimics an Adenoid Basal Tumor. [PDF]
Satoskar S +4 more
europepmc +1 more source
ABSTRACT Background Light changes during the lunar cycle affect rhythms in diverse species. Human studies focusing on whether the moon influences human health have so far neglected the effects of light/dark cycles. The purpose of this study was to investigate whether lunar phases impact perinatal outcomes by considering illumination levels due to day ...
Karin Windsperger +6 more
wiley +1 more source
Clear Cell Carcinoma of the Uterine Cervix in a 14-Year-Old Girl: A Case Report. [PDF]
Motomura M +4 more
europepmc +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Primary lymphoma of the uterine cervix: A systematic review and integrated analysis of case reports and series. [PDF]
Kechagias KS +12 more
europepmc +1 more source
This study is the first to identify a novel neutrophil subpopulation, N4, that is closely associated with the progression of cervical cancer. Characterized by high PLAU expression and specific interactions with tumor cells, N4 neutrophils were shown to promote tumor growth and immune modulation.
Ze Wang +7 more
wiley +1 more source

